HER2 expression and pathway status in male breast cancer patients: results of an integrated analysis among 6,150 patients
Abstract The role of human epidermal growth factor 2 (HER2) in male breast cancer (MBC) is poorly defined. A comprehensive description of HER2 status was conducted. A total of 6,015 MBC patients from 45 studies and 135 MBC patients with sequencing data were identified. HER2 positive rates and hazard...
Saved in:
Main Authors: | Boqiang Lyu, Shidi Zhao, Hui Wang, Shouping Gong, Biyuan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86556-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
by: Satomi Watanabe, et al.
Published: (2019-03-01) -
A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer
by: Danilo Giffoni de Mello Morais Mata, et al.
Published: (2024-12-01) -
The Use of Fluorescence In situ Hybridisation in the Diagnosis of Hidden Mosaicism in Egyptian Patients with Turner Syndrome
by: Heba Mohamed Ossama, et al.
Published: (2023-10-01) -
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
by: Ji‐Hua Shi, et al.
Published: (2019-03-01) -
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
by: Hossein Schandiz, et al.
Published: (2025-01-01)